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Correspondence
In Brief Sadahiro et al. show that Tbx6 is critical for mesoderm induction and subsequent lineage diversification from pluripotent stem cells (PSCs). Transient Tbx6 expression induced nascent mesoderm and cardiovascular lineages from mouse and human PSCs, whereas prolonged Tbx6 expression suppressed cardiac differentiation and induced somite lineages, including skeletal muscle and chondrocytes.
SUMMARY
The mesoderm arises from pluripotent epiblasts and differentiates into multiple lineages; however, the underlying molecular mechanisms are unclear. Tbx6 is enriched in the paraxial mesoderm and is implicated in somite formation, but its function in other mesoderms remains elusive. Here, using direct reprogramming-based screening, single-cell RNA-seq in mouse embryos, and directed cardiac differentiation in pluripotent stem cells (PSCs), we demonstrated that Tbx6 induces nascent mesoderm from PSCs and determines cardiovascular and somite lineage specification via its temporal expression. Tbx6 knockout in mouse PSCs using CRISPR/Cas9 technology inhibited mesoderm and cardiovascular differentiation, whereas transient Tbx6 expression induced mesoderm and cardiovascular specification from mouse and human PSCs via direct upregulation of Mesp1, repression of Sox2, and activation of BMP/Nodal/Wnt signaling. Notably, prolonged Tbx6 expression suppressed cardiac differentiation and induced somite lineages, including skeletal muscle and chondrocytes. Thus, Tbx6 is critical for mesoderm induction and subsequent lineage diversification.
INTRODUCTION
In mammals, all organs are derived from three primary germ layers, mesoderm, endoderm, and ectoderm. Nascent mesoderm is induced as epiblast cells ingress through the primitive streak (PS), and distinct mesoderm populations are specified according to the timing and order of cell migration. The heart is derived from lateral/cardiac mesoderm and is the first functional organ to be formed in embryos. The lateral/cardiac mesoderm arises from the mid PS and moves anteriorly to be specified to cardiac progenitor cells (CPCs) that differentiate into cardiomyocytes (CMs), smooth muscle cells (SMCs), and endothelial cells (ECs) (Paige et al., 2012; Wamstad et al., 2012) . The paraxial/presomitic mesoderm subsequently arises from the anterior PS and differentiates into the somite, in which the axial skeleton, skeletal muscle, and dermis are formed (Loh et al., 2016) . Understanding the regulation of mesoderm development is critical for generating each of these cell types and elucidating the mechanisms of congenital diseases.
Pluripotent stem cell (PSC)-based differentiation recapitulates the developmental process in embryos and represents a valuable platform to study the mechanisms of cell-fate specification. Previous studies have revealed that temporal activation and inhibition of bone morphogenic protein (BMP), Nodal/Activin, and Wnt signaling induced nascent mesoderm and multiple mesodermal derivatives from PSCs. Wnt activation induced nascent mesoderm from PSCs, but, once mesoderm was induced, inhibition of Wnt signaling was necessary for cardiac specification and prolonged Wnt/b-catenin activation inhibited cardiac differentiation and instead, induced other lineages, including paraxial mesoderm (Burridge et al., 2014; Kattman et al., 2011; Lian et al., 2012; Loh et al., 2016) . Despite recent success in directed differentiation from PSCs with a series of small molecules and cytokines, the molecular mechanisms for mesoderm induction and lineage diversification remain elusive, since mesoderm development is a dynamic process and the sample sizes were too small for conventional genome-wide analyses. Recent single-cell RNA sequencing (RNA-seq) profiling revealed the landscape for temporal and spatial changes of gene expression in early/nascent mesoderm and subsequent lineage specification in vivo and in vitro (Loh et al., 2016; Scialdone et al., 2016) . However, a single transcription factor sufficient to induce nascent mesoderm without exogenous factors is unknown, and regulatory mechanisms for mesodermal lineage diversification remain poorly understood.
Direct reprogramming may identify new key regulators for lineage commitment via screening of candidate genes. Overexpression of reprogramming factors in fibroblasts may induce new programs of desired cell types within a week, which might be simpler and faster than generating multiple PSC-lines expressing a series of candidate genes. We previously demonstrated that a combination of cardiac-enriched transcription factors, Gata4, Mef2c, and Tbx5, directly reprogrammed mouse fibroblasts into functional CMs by screening 14 factors Sadahiro et al., 2015) ; however, genes that induce nascent mesoderm have not been identified.
Tbx6 is a T-box transcription factor enriched in paraxial/presomitic mesoderm. Tbx6 has been implicated in somite formation, with Tbx6 mutant mice generating two ectopic neural tubes at the expense of somite formation, but its expression and function in early/nascent mesoderm and other mesodermal derivatives, including cardiovascular lineages, remain largely unknown (Chapman and Papaioannou, 1998; Takemoto et al., 2011; Wardle and Papaioannou, 2008) . Here, we attempted to identify a defined factor that could induce nascent mesoderm from mouse and human PSCs in the absence of exogenous factors and determine its function in mesodermal lineage diversification.
RESULTS

Direct Reprogramming-Based Screening Identified Tbx6 as a Mesoderm-Inducing Factor in Mouse Fibroblasts
To identify new key regulators for nascent mesoderm, we adopted direct reprogramming-based screening. We selected 58 candidate transcription factors expressed in mesodermal lineages and important for development, including Eomes, Ets2, Lef1, Tcf3, Smads, T, Tbx3, and Tbx6 (Islas et al., 2012; Weidgang et al., 2013) . These 58 genes were cloned individually into pMX retroviral vectors for efficient and continuous gene expression in fibroblasts . We used mouse embryonic fibroblasts (MEFs) that were not contaminated with nascent mesoderm and cardiovascular cells. We transduced each retroviral vector into MEFs and analyzed the induction of Mesp1, a marker for early/nascent mesoderm, after 1 week of transduction. Intriguingly, among 58 factors, only Tbx6 strongly induced Mesp1 mRNA expression ( Figure 1A) . Moreover, the addition of Eomes or T, two other mesoderm-enriched T-box transcription factors, to Tbx6 did not further upregulate Mesp1 expression in MEFs ( Figure 1B ). We next utilized MEFs from Mesp1 cre/+ (Mesp1-Cre)/GFP-flox mice, in which the Mesp1expressing mesoderm and its progeny can be traced by GFP expression (Saga et al., 1999) . We found that Tbx6-transduced MEFs expressed GFP, which was not detected in the uninfected MEFs. The Mesp1-Cre/GFP + cells formed multiple colonies but did not proliferate indefinitely, similar to those in vivo ( Figure 1C ). We also analyzed the expression of T/Brachyury, another marker of nascent mesoderm. Immunostaining demonstrated that T protein was also expressed in the Tbx6-transduced cell nuclei after 4 weeks ( Figure 1D ). Next, we analyzed two surface markers for mesoderm, Flk1 and PDGFRa (Kattman et al., 2011; Liu et al., 2016) . Fluorescence-activated cell sorting (FACS) analyses revealed that Flk1 and PDGFRa-double positive cells, markers for lateral/ cardiac mesoderm population, were detected in $5% of the Tbx6-transduced fibroblasts after 4 weeks ( Figure 1E ). We next analyzed the gene expression profile related to the mesoderm (Mesp1, T, Flk1), CPCs (Isl1, Nkx2.5, Gata4), CMs (Tnnt2, Myh6), SMCs (Myh11), ECs (Pecam1), and skeletal muscles (Pax3, Pax7, Myod1, Myf5), in Tbx6-transduced MEFs over time. qRT-PCR analyses revealed that mesoderm-related genes were upregulated and remained high even after 4 weeks, whereas the expression of CPC, CM, SMC, EC, and skeletal muscle genes was not activated, except for Isl1, a marker for early CPCs ( Figure 1F ). These results suggest that continuous Tbx6 expression induced and maintained an early/nascent mesoderm program in mouse fibroblasts.
Single-Cell RNA-Seq Revealed that Tbx6 + Nascent Mesoderm Expresses Genes Related to Cardiovascular Mesoderm and Early CPCs in Mouse Embryos Tbx6 is essential for the development of somites. Tbx6 expression is first detected in the PS at embryonic day (E) 7.0 during gastrulation and later restricted in the paraxial/presomitic mesoderm and tail bud from E8.5 to E12.5 in mouse embryos (Chapman et al., 1996) . However, the precise nature of the early mesoderm population expressing Tbx6 remains unclear, because the cell numbers are too small for conventional genome-wide analyses. To investigate the spatiotemporal transcriptional profiles associated with Tbx6 expression in mouse embryos, we analyzed the publicly available single-cell RNA-seq data for the 682 single cells of the FACS Flk1 + mesoderm and CD41 + cells in mouse embryos at E7.0-7.75 . The t-distributed stochastic neighbor embedding (t-SNE) projection and expression of key marker genes divided the single cells into seven major groups: nascent mesoderm, posterior mesoderm, endothelium, blood progenitors, embryonic blood, allantois, and pharyngeal mesoderm ( Figure S1A ). Among them, Tbx6 was specifically expressed in a large population of the E7.0 nascent mesoderm group (Figure 2A ). Tbx6 expression was correlated with other nascent mesoderm-associated genes, including T, Mixl1, and Mesp1, with Mesp1 more broadly expressed in this and other populations, such as the posterior and pharyngeal mesoderm, consistent with its known expression profile Saga et al., 1999) . Intriguingly, Tbx6 + nascent mesoderm was correlated with the expression of lateral/cardiac mesoderm genes (Flk1, Pdgfra) and early CPC genes (Isl1, Gata4) rather than paraxial/presomitic mesoderm genes (Msgn1, Meox1) at this early stage. Tbx6 + mesoderm cells neither expressed late CPC/CM genes (Nkx2.5, Tbx5), skeletal muscle genes (Pax3, Pax7, Myod1, Myf5), nor a definitive endoderm gene (Foxa2) ( Figures 2B and S1B) . These results suggest that Tbx6 is expressed in the nascent mesoderm population related to cardiovascular mesoderm/ progenitors rather than paraxial/presomitic mesoderm in early mouse embryos. 
Tbx6 Is Critical for Mouse ESC Differentiation into Mesoderm and Cardiovascular Lineages
Next, to investigate the kinetics and roles of Tbx6 in cardiogenesis in detail, we used a mouse ESC-based directed cardiac differentiation system, in which the mesoderm, CPCs, and CMs were sequentially induced (Kattman et al., 2011) . T GFP/+ mouse ESCs (T-GFP ESCs) were used to mark the nascent mesoderm population . Embryoid bodies (EBs) were generated and cultured for 2 days in the absence of exogenous factors (days 0-2), subsequently treated with Activin A, BMP4, and vascular endothelial growth factor (VEGF) (ABV) for 2 days to induce mesoderm under serum-free conditions (days 2-4), and then dissociated to a monolayer culture to differentiate into CPCs and CMs (days 4-14) ( Figure 3A ). This directed cardiac differentiation protocol efficiently specified the T-GFP ESCs into mesoderm and CMs (Figures 3B-3D and S2A). qRT-PCR revealed that Tbx6 mRNA expression was rapidly induced at the mesoderm stage, peaking on day 4, and was sharply downregulated thereafter. This was similar to the kinetics of other nascent mesodermal genes, such as Eomes, T, and Mesp1, but not to those of paraxial mesoderm genes (Msgn1, Meox1, Tcf15) or skeletal muscle genes (Pax3, Pax7, Myog) ( Figures 3C and S2B ). The CPC and CM genes Nkx2.5, Tnnt2, and Myh6 were induced from day 6, and Isl1 expression started on day 4 and peaked on day 6. Thus, the expression kinetics of Tbx6 in vitro is consistent with the single-cell RNA-seq results in early mouse embryos. Next, to determine whether Tbx6 is expressed in the mesoderm but not in other populations in day 4 EBs, we used FACS to sort T-GFP + and T-GFPcells for the analysis of gene expression ( Figures 3B and 3D ). Tbx6 expression was significantly enriched in the T-GFP + population, corresponding to T and Mesp1 expression, whereas Sox2 was expressed in T-GFPcells, suggesting that Tbx6 was expressed in the mesoderm ( Figure 3D ).
It has been reported that neuromesodermal progenitors (NMPs; T and Sox2 double-positive cells) play a role in embryonic development and differentiate into both neural and mesodermal lineages (Gouti et al., 2014) . We next tested whether NMPs were induced in this directed cardiac differentiation protocol. qRT-PCR and immunocytochemistry revealed that T + /Sox2 + NMPs were not induced prior to Next, to investigate whether Tbx6 is critical for mesoderm specification and cardiovascular differentiation in mouse ESCs, we generated Tbx6 knockout (KO) ESCs using the CRISPR/Cas9 system ( Figure 3E ). To generate Tbx6 KO ESCs, guide RNA was targeted to the first exon of Tbx6, an RFP and blasticidin cassette was knocked into one allele, and CRISPR/Cas9-mediated DNA deletion leading to frameshift mutation was introduced into another allele in E14 wildtype (WT) ESCs. DNA sequencing and PCR analyses confirmed the integrity of three clonal Tbx6 KO ESC lines (clones #1-3, Figures S3A-S3C ). We first differentiated clone #1 Tbx6 KO ESCs into cardiovascular lineages with directed differentiation and compared these to the parental WT ESCs (Figure 3F ). qRT-PCR demonstrated that T, Mesp1, and Eomes mRNA expression was significantly downregulated in the Tbx6 KO EBs on day 4 ( Figure 3G ). Consequently, induction of Flk1 + /PDGFRa + presumptive lateral/cardiac mesoderm was significantly suppressed in the Tbx6 KO EBs compared to that in WT EBs ( Figures 3H and 3J ). Moreover, cardiac differentiation, determined by the presence of cTnT + cells, was significantly reduced in clone #1 Tbx6 KO ESCs to one-third of that in WT ESCs on day 14 ( Figures 3I and 3J ). qRT-PCR analyses also revealed that multiple cardiovascular genes, including Actn2, Tnnt2, Nkx2.5, Myh11, and Pecam1, were suppressed in the Tbx6 KO ESCs ( Figure S3D ). Next, to determine the reproducibility of multiple Tbx6 KO ESC lines in mesoderm and CM induction, we analyzed two other Tbx6 KO ESC lines (clone #2 and #3). FACS analyses revealed that induction of Flk1 + /PDGFRa + and cTnT + cells was significantly suppressed in the clone #2 and #3 Tbx6 KO ESCs (Figures 3J, S3E , and S3F). These results suggest that Tbx6, transiently expressed in the nascent mesoderm, is critical for mouse ESC differentiation into mesoderm and subsequent cardiovascular lineages.
Transient Tbx6 Expression Induces Mesoderm and Cardiovascular Lineages in Mouse ESCs
Next, to investigate the effect of Tbx6 on mesoderm induction and cardiovascular differentiation in ESCs, we generated clonal T-GFP mouse ESC lines, in which the expression of FLAG-tagged mouse Tbx6 could be induced by doxycycline (Dox) administration and mesoderm induction could be monitored by GFP expression (iTbx6 T-GFP mESCs) ( Figures 4A and 4B ). Humanized Kusabira-Orange fluorescence (hKO) was used for homogeneous and clonal expansion of the mouse ESCs, and Tbx6 expression was confirmed following Dox administration ( Figures 4B, 4C , and S4A). As a control experiment, we first confirmed that iTbx6 T-GFP mESCs efficiently differentiated into mesoderm and CMs by the addition of multiple cytokines (Activin A, BMP4, and VEGF: ABV) with similar efficiency to those in parental mouse ESCs, suggesting that they possessed intact differentiation potential (ABV, . In contrast, in the absence of cytokines (ABV) and Dox administration (No Dox), the mouse ESCs never differentiated into T-GFP + or Flk1 + /PDGFRa + mesoderm and CMs (No Dox, . Notably, Dox administration alone (Dox on) induced T-GFP + and Flk1 + /PDGFRa + mesoderm in the iTbx6 T-GFP mESCs in a time-dependent manner. The efficiency of mesoderm induction by Dox administration from days 0-3 was comparable to those with the directed cardiac differentiation using ABV (Dox on D0-3, Figures 4D-4G and S4B). Induction of Tbx6 on days 0-2 or 2-3 showed minimal effects, suggesting that the expression of Tbx6 for the first 3 days is critical for efficient mesoderm and cardiac induction ( Figures 4D-4J and S4C). To determine the dose dependency and reproducibility of mesoderm induction by Tbx6, we next analyzed nine independent clonal iTbx6 T-GFP mESC lines, in which Tbx6 was differentially induced with Dox ( Figure S4D ). The mouse ESC lines expressing high Tbx6 levels (clones #7, 8, 9) showed the highest and comparable T-GFP induction, whereas cells expressing low (clones #1-3) or intermediate (clones #4-6) Tbx6 levels demonstrated lower induction of T-GFP ( Figures S4D-S4F ). These results suggested that transient Tbx6 expression was sufficient for the induction of mesoderm from mouse ESCs without the need for exogenous factors.
We next analyzed whether Tbx6-induced mesoderm could differentiate into cardiovascular lineages. The mesoderm generated by Dox administration from days 0-3 induced $60% of cTnT + cells after 14 days, which was comparable to that with the cytokine-based cardiac differentiation; Tbx6induced CMs beat robustly and synchronously in culture (Dox on D0-3, Figures 4H-4J , Video S1). We also found that prolonged Tbx6 expression (longer than 3 days) suppressed cardiac differentiation ( Figures 6B and 6C ). Immunostaining demonstrated that Tbx6-induced mesoderm differentiated into all three cardiovascular lineages (Dox on D0-3), including CMs, SMCs, and ECs, whereas no cardiovascular cells were generated without Dox addition (No Dox, Figures 4K and S4G) . qRT-PCR also revealed that the expression of cardiovascular genes was significantly induced with Dox addition ( Figure 4L ). Thus, transient Tbx6 expression induced mesoderm and subsequent cardiovascular differentiation in mouse ESCs. 
Tbx6 Activates Mesoderm and Endoderm Programs and Represses Neuroectoderm Genes in Mouse ESCs
Next, to investigate the mechanisms responsible for Tbx6-mediated mesoderm induction in mouse ESCs, we performed microarray analyses and analyzed differentially expressed genes in iTbx6 T-GFP mESCs on days 2 and 4 with or without Dox administration ( Figure 5A ). Hierarchical clustering and gene ontology (GO) analyses revealed that the genes upregulated on day 2 were enriched for GO terms associated with the BMP signaling pathway, heart development, and angiogenesis, whereas downregulated genes were enriched for GO terms related to neural development ( Figures 5A and 5B ). Upregulated genes on day 4 were related to the transforming growth factor b (TGF-b) and BMP signaling pathways, PS and endoderm formation, and blood vessel and heart development, while downregulated genes were associated with neural/brain development ( Figures 5A and 5C ). Scatterplot analyses demonstrated that mesoderm-and endoderm-enriched genes were significantly upregulated with Dox administration (Figure S5A ). Microarray and qRT-PCR analyses revealed that mesoderm and endoderm genes related to different functions, such as transcription factors (Eomes, T, Mesp1, Isl1, Gsc, Sox17) , signaling molecules (Bmp4, Nodal, Wnt3), and cell-surface markers (Flk1, Pdgfra), were greatly upregulated with Dox addition, whereas neuroectoderm transcription factors (Pax6 and Sox1) were significantly downregulated by Dox addition (Figures 5D and S5B) . Thus, Tbx6 expression activated mesoderm and endoderm programs and concomitantly suppressed neuroectoderm gene expression in mouse ESCs to induce a mesodermal program.
Tbx6 Directly Upregulates Mesp1, Inhibits Sox2, and Activates BMP/Nodal/Wnt Paracrine Signaling in Mouse ESCs We next asked how Tbx6 globally regulated gene expression associated with developmental events in mouse ESCs. Among mesoderm genes upregulated by Tbx6, Mesp1 is a key transcription factor for mesoderm induction and was upregulated in both mouse ESCs and fibroblasts with Tbx6 overexpression ( Figures  1A and 5D ) . Mesp1 contains two conserved T-box consensus binding sites (TCACAC) at the enhancer region (À4 kb) and near the transcriptional start site (TSS, +0.1 kb) ( Figures 5E and 5F ). To determine whether Tbx6 directly bound and upregulated Mesp1 expression, we performed chromatin immunoprecipitation (ChIP)-qPCR analyses with antibodies against Tbx6-FLAG, PolII, and immunoglobulin G (IgG) in iTbx6 T-GFP mESCs. Tbx6 binding was clearly observed at the À4-kb early mesoderm enhancer region with Dox administration, whereas it was not detected at the TSS or a +1.2-kb negative-control region, which did not contain T-box-binding sites ( Figure 5F ). PolII binding was increased at the TSS with Dox addition, suggesting PolIIdependent Mesp1 gene transcription ( Figure 5G ). Thus, Tbx6 directly upregulated Mesp1 expression. We next asked how Tbx6 globally suppressed the neural program. Sox2 is a key transcription factor for neural development, and suppression of Sox2 is critical for mesoderm and endoderm induction in human PSCs (Rao et al., 2016) . qRT-PCR revealed that Sox2 was strongly (legend continued on next page) downregulated by Tbx6 ( Figure S5C ). ChIP-qPCR analyses for Tbx6 and PolII binding demonstrated that Tbx6 binding was significantly enriched on two of four T-box-containing regions (À10 and +4 kb) in the Sox2 gene, whereas PolII binding was not enriched at the TSS after Dox administration (Figures S5D  and S5E ). Thus, Tbx6 directly suppressed Sox2 expression in mouse ESCs. Moreover, Tbx6 overexpression did not induce T + /Sox2 + NMPs prior to mesoderm differentiation in iTbx6 T-GFP mESCs ( Figure S5F ).
We next sought to characterize the regulation of BMP, Nodal, and Wnt signaling in Tbx6-induced mesoderm in mouse ESCs. Consistent with the GO analysis, kinetic analyses for Bmp4, Nodal, and Wnt3 mRNA expression demonstrated that Bmp4 was rapidly and strongly upregulated after 12 hr of Dox administration, whereas Nodal and Wnt3 expression were activated later ( Figure 5H ). These results suggest that Bmp4 might be a primary target of Tbx6 and activation of Nodal/Wnt3 was a secondary effect, consistent with the known effect of Bmp4 to induce Wnt and Nodal during mesoderm development (Murry and Keller, 2008) . Indeed, ChIP-qPCR revealed that Dox addition enriched Tbx6 and PolII binding at the Bmp4 gene (+0.3 and +0.5 kb) and TSS, respectively ( Figures S5G and S5H) . Given that Bmp4, Nodal, and Wnt3 expression were upregulated with Tbx6, we next asked whether these signaling pathways were critical for Tbx6-mediated mesoderm induction. We treated iTbx6 T-GFP mESCs with specific inhibitors for the BMP, Nodal, and Wnt signaling pathways in combination with Dox treatment. T-GFP induction was significantly reduced with these three inhibitors, suggesting that the activation of BMP, Nodal, and Wnt pathways were all required for Tbx6-mediated mesoderm induction (Figures S5I and S5J) . Next, to determine whether Tbx6 induced mesoderm through non-cell-autonomous/paracrine mechanisms, we generated chimeric EBs, in which iTbx6 T-GFP mESCs (inducer, hKO + ) were mixed with parental T-GFP mESCs (responder, hKO -). The chimeric EBs were treated with Dox without cytokines and analyzed for Flk1 and PDGFRa mesoderm induction by FACS. Dox administration induced Flk1 + /PDGFRa + mesoderm in both hKO + and hKOcells; however, the induction rate was significantly higher in the inducer, suggesting that Tbx6 induced mesoderm through both cell-autonomous and non-cellautonomous mechanisms ( Figure 5I ). Thus, Tbx6 directly regulates Mesp1, Sox2, and Bmp4 expression and activates BMP/ Nodal/Wnt pathways through non-cell-autonomous/paracrine mechanisms to induce mesoderm in mouse ESCs.
Prolonged Tbx6 Expression Inhibits Cardiovascular Differentiation and Induces Paraxial Mesoderm and Somite Lineages in Mouse ESCs
After transient expression of Tbx6 in nascent mesoderm, Tbx6 is continuously expressed in the paraxial/presomitic mesoderm and tail bud in mouse embryos until somite formation (Chapman et al., 1996) . The ventral somite (sclerotome) generates the cartilage and vertebral column, whereas the dorsal somite (dermomyotome) forms skeletal muscles and the dermis of the back (Loh et al., 2016) . However, it remains unknown whether Tbx6 expression is sufficient to induce paraxial mesoderm and somite lineages in ESCs. To address this, we continuously expressed Tbx6 in iTbx6 mESCs by prolonged Dox administration without the addition of exogenous factors (Figures 6A-6C) . Remarkably, continuous Tbx6 expression decreased Flk-1 + /PDGFRa + cardiogenic mesoderm and increased the Flk-1 -/PDGFRa + population (presumptive paraxial mesoderm) in a time-dependent manner ( Figures 6A and 6C) . Analyses of multiple clonal iTbx6 mESC lines revealed that Flk-1 -/PDGFRa + cells were induced from ESCs by Tbx6 in a dose-dependent manner; in addition, in the absence of Dox and exogenous factors, no mesodermal cells were induced from mouse ESCs (Figures S6A and S6B) . Consistent with the induction of Flk-1 -/PDGFRa + population, the paraxial/presomitic mesoderm genes (Meox1, Msgn1, and Tcf15) were significantly upregulated on day 5 by continuous Dox administration ( Figure 6F) . In contrast to the robust cardiac differentiation by transient Tbx6 expression, continuous Tbx6 expression suppressed cardiovascular differentiation in a timedependent manner ( Figures 6B-6D ). Next, to determine whether prolonged Tbx6-induced mesoderm could differentiate into somite lineages, we treated the cells with the ROCK inhibitor, Y27632, to induce skeletal myocyte differentiation (Figure 6E ). Gene expression analyses revealed that continuous Tbx6 expression for 8 days led to the upregulation of skeletal myocyte genes (Myog, Acta1, and Myh3) on day 14 (Dox on D0-8, Figure 6F ). Immunohistochemistry demonstrated that skeletal myoblasts characterized as MyoD + and Myogenin + were induced under the conditions of differentiation (Dox on D0-8, Figures 6G and 6J) , and multinucleated myosin heavy chain (MHC) + myocytes were induced after 3 weeks of culture ( Figures 6I-6K ). Skeletal myocytes/myoblasts were never induced without Dox administration (No Dox). Next, to investigate whether Flk-1 -/PDGFRa + mesoderm could also differentiate into other somite lineages, we treated the cells with growth and differentiation factor 5 (GDF-5; also known as BMP14), a member of the TGFb superfamily, to induce chondrocytes (Figure S6C) . qRT-PCR analyses revealed that Dox administration upregulated the expression of chondrocyte-enriched genes, Sox9 and Col2a1 (Dox on D0-8, Figure S6D ). Safranin-O staining and immunohistochemistry for Sox9 and Col2a1 demonstrated chondrocyte induction from mouse ESCs by Tbx6 expression for 8 days (Dox on D0-8, Figures S6E and S6F ). If Tbx6 was further continuously expressed, neither cardiovascular or somite lineage was induced (data not shown). Thus, prolonged Tbx6 expression inhibited cardiovascular differentiation and instead induced paraxial mesoderm and somite lineages in mouse ESCs, consistent with the kinetics of Tbx6 in vivo. (legend continued on next page) Next, we investigated how temporal Tbx6 expression regulates mesodermal lineage specification. We analyzed the expression of Wnt3, Msx1, and Cdx2, which are implicated in paraxial mesoderm development (Rao et al., 2016) . qRT-PCR revealed that Wnt3 was strongly upregulated with continuous Tbx6 expression, peaking on day 5. Msx1 and Cdx2, targets of Wnt signaling, were subsequently induced with prolonged Tbx6 expression, peaking on day 6 ( Figure S7A ). We next overexpressed Msx1 and Cdx2 in iTbx6 mouse ESCs with transient Dox administration to determine their roles in Tbx6-induced differentiation ( Figure S7B ). FACS analyses and immunohistochemistry revealed that overexpression of Msx1 and Cdx2 strongly inhibited cardiac differentiation, suggesting that temporal Tbx6 expression regulates cardiac versus somite lineage differentiation, at least in part, via Wnt3, Msx1, and Cdx2 expression ( Figures S7C and S7D ).
Transient Tbx6 Expression Induces Mesoderm and Cardiovascular Lineages in Human PSCs
Mouse and human PSCs represent different stages of development, but the signaling pathways that regulate their differentiation are similar (Kattman et al., 2011) . We next investigated the role of Tbx6 in human cardiovascular differentiation using human induced PSCs (hiPSCs), 253G4. Directed cardiac differentiation using a series of multiple cytokines and small molecules sequentially specified the hiPSCs into mesoderm, CPCs, and CMs (Figure 7A) . qRT-PCR revealed that Tbx6 expression rapidly increased on day 2, one day after the induction of T and Eomes expression, and sharply decreased on day 4. This kinetics was similar to that of Mesp1, whereas Nkx2.5 and Tnnt2 were induced thereafter, suggesting that Tbx6 was transiently induced at a mesoderm stage before CPC and CM differentiation in human PSCs ( Figure 7B ).
Next, we generated clonal hiPSC lines, in which human Tbx6 could be induced by Dox administration (iTbx6 hiPSCs) ( Figures  7C and 7F) . Without the addition of exogenous factors and Dox (No Dox), the iTbx6 hiPSCs never differentiated into T + mesoderm. In contrast, Dox administration alone was sufficient to induce $50% of T + nascent mesoderm in the iTbx6 hiPSCs without the addition of cytokines, as shown by FACS and immunohistochemistry (Dox on, Figures 7D and 7E ). Gene expression analyses revealed that mesoderm, signaling molecules, and mesendoderm-related genes, such as T, Mesp1, Pdgfra, Wnt3a, Bmp4, Nodal, and Eomes, were greatly upregulated with Dox addition, whereas the neural transcription factor, Sox2, was downregulated in the hiPSCs, similar to mouse ESCs ( Figure 7F ). We next asked whether Tbx6-induced mesoderm could differentiate into cardiovascular lineages in hiPSCs.
To determine the appropriate timing of Dox addition for cardiac induction, we sequentially treated the hiPSCs with Dox and analyzed cardiac induction by FACS after 14 days of differentiation ( Figure 7G ). For the iTbx6 hiPSCs, Dox administration from days À1 to 0 was found to be optimal to induce 15% of cTnT + cells, which represents, however, a lower efficiency than that in iTbx6 mESCs ( Figures 4I and 7H) . The Tbx6-induced human CMs beat synchronously in culture (Video S2). qRT-PCR and immunostaining demonstrated that Tbx6-induced mesoderm differentiated into all three cardiovascular lineages, whereas no cardiovascular differentiation was observed without Dox treatment ( Figures 7I and 7J) . Thus, transient Tbx6 expression also induced mesoderm and cardiovascular lineages in human PSCs, similar to the results in mouse ESCs.
DISCUSSION
Tbx6 has been regarded as a marker of paraxial mesoderm and implicated mainly in somite development in mammals (Chapman and Papaioannou, 1998; Loh et al., 2016) . Here, we reveal an essential and unexpected function of Tbx6 in nascent mesoderm induction and subsequent lineage diversification into cardiovascular and somite lineages in PSCs regulated by its temporal expression. Transient Tbx6 expression induced cardiac/lateral mesoderm and cardiovascular lineages, while continuous Tbx6 expression suppressed cardiac differentiation and induced paraxial/presomitic mesoderm and somite lineage specification.
We screened key regulators for mesoderm induction in mouse fibroblasts with the direct reprogramming approach. Fibroblasts are efficiently transduced with retroviral vectors without gene silencing and are easier and cheaper to culture than PSCs. We found that Tbx6 induced a nascent mesoderm-like program in fibroblasts by screening of 58 factors. Although the precise mechanisms remain undetermined, we found that Tbx6 induced mesoderm-related genes but not genes related to differentiated cardiovascular cells or skeletal myocytes, suggesting that Tbx6 induced and maintained a mesodermal program in fibroblasts. Consistent with our results, Tbx6 is expressed in nascent mesoderm, and subsequently in paraxial mesoderm, but not in somites or other differentiated derivatives in vivo (Chapman et al., 1996) . These results suggest that Tbx6 induces the mesoderm program but that suppression of Tbx6 may be a prerequisite for mesoderm differentiation. Given that the gene regulatory networks of programming (differentiation) and reprogramming are similar, the direct reprogramming-based approach we describe here might be applicable in general for the identification of new key regulators and their functions in cell-fate decision.
Tbx6 + nascent mesoderm is a transient population, arising early in gastrulation, but the nature of this population remained unclear, because the genome-wide transcriptional profile has not been determined owing to the small sample size. We revealed a detailed molecular signature of Tbx6 + nascent mesoderm cells in E7.0 mouse embryos by analyzing singlecell RNA-seq. Single-cell RNA-seq demonstrated that the Tbx6 + mesoderm progenitors were a highly homogeneous population, expressing not only nascent mesoderm genes but also lateral/cardiac mesoderm and early CPC genes, suggesting they might be transitioning from nascent mesoderm to cardiovascular lineages. We also found that Tbx6 was expressed in the mesoderm before cardiac progenitors and cardiac differentiation in PSC-based directed cardiac differentiation. Thus, our characterization of the Tbx6 + nascent mesoderm in single-cell analyses revealed a connection between early Tbx6 expression and cardiovascular lineage differentiation, and such single-cell analyses may change our current view of lineage specification during development. Consistent with our results, Concepcion et al. have recently reported that the progeny of the Tbx6 + nascent mesoderm was distributed not only in the paraxial mesoderm and somites, but also in the lateral/cardiac mesoderm, heart, and blood vessel endothelium by analyzing Tbx6-creERT2 lineage tracing mice (Concepcion et al., 2017) .
Although Tbx6 has been regarded to function mainly in somite development in mammals, Tbx6 is critical for cardiac mesoderm formation and cardiogenesis in lower organisms. Drosophila lacking the Tbx6 homolog Dorsocross do not form a dorsal vessel, which is equivalent to the heart. In Ciona intestinalis, the ortholog of Tbx6 acts upstream of Mesp to form the cardiac mesoderm (Christiaen et al., 2009; Reim and Frasch, 2005; Satou et al., 2004) . In mammals, Tbx6 mutant mice show dramatic defects in somite formation and die at mid-gestation. However, they also exhibit cardiovascular defects such as a lack of heartbeats, abnormal heart looping, and vascular hemorrhages, although the underlying mechanisms of these cardiovascular defects remain poorly understood (Chapman and Papaioannou, 1998) . In humans, heart abnormalities such as ventricular septal defects were recently reported in two out of nine Japanese congenital scoliosis patients with TBX6 mutations (Takeda et al., 2017) . Consistent with these cardiovascular defects in mammals, we found that KO of the Tbx6 gene inhibited mesoderm specification and cardiovascular differentiation in mouse ESCs. A previous study showed that Tbx6 KO mouse ESCs differentiated into contractile EBs similar to WT ESCs under fetal bovine serum (FBS)-mediated hanging drop differentiation; however, this may underestimate the effect of Tbx6 on cardiac differentiation, as the authors did not quantify the efficiency of mesoderm and cardiovascular differentiation using FACS or qRT-PCR (Chapman et al., 2003) . Thus, our study revealed an essential and unappreciated function of Tbx6 in mesoderm and cardiovascular specification conserved from lower organisms to mammals. Although there are cardiovascular defects in Tbx6 KO mice, myocardial tissues develop in the mutant mice. It is conceivable that the redundancy with other T-box genes (T, Eomes, Mesp1) may compensate for the cardiac phenotype in Tbx6 KO mice. Indeed, we found that expression of T, Mesp1, and Eomes, as well as cardiac differentiation, was suppressed but not completely ablated in Tbx6 KO ESCs. Thus, Tbx6 is important but not required for mesoderm formation and cardiac development in mammals.
We also found that Tbx6 overexpression, in the absence of exogenous cytokines, was sufficient to induce nascent mesoderm that subsequently differentiated into cardiovascular lineages in mouse and human PSCs. Although the expression and function of Tbx6 were similar in mice and humans, there were some notable differences. The timing and duration of Tbx6 expression for optimal cardiac differentiation differed, and the efficiency of T + mesoderm and CM induction was substantially lower in humans. Some of these differences may be attributable to distinct pluripotent states, endogenous signaling, and transgene expression between human and mouse PSCs (Kattman et al., 2011) . Nonetheless, these results further demonstrate an evolutionarily conserved role of Tbx6 in mesoderm specification and subsequent cardiovascular differentiation in mammals. Consistent with our findings, Gavrilov et al. reported the positive effects of Tbx6 in promoting cardiac differentiation and repressing neural differentiation using the mouse embryonic carcinoma P19CL6 cell line (Gavrilov et al., 2012) .
Mechanistically, Tbx6 induced mesoderm by directly activating Mesp1 and BMP4 and repressing Sox2, and presumably, indirectly inducing Wnt and Nodal expression. Activation of BMP4, Nodal, and Wnt pathways by Tbx6 expression non-cellautonomously induces mesoderm specification, which may in turn upregulate Tbx6 expression and create a positive feedback loop for robust induction of mesoderm. We also found that prolonged Tbx6 expression continuously upregulated Wnt3 expression after mesoderm induction, which subsequently induced Msx1 and Cdx2 expression and interfered with cardiac differentiation. Such mechanisms may be responsible for Tbx6-mediated mesoderm induction and subsequent lineage diversification. Although prolonged Tbx6 expression-induced mesoderm differentiated into skeletal myocytes with the ROCK inhibitor, other protocols were not as efficient as the ROCK inhibitor treatment in our ESC lines (data not shown) (Chal and Pourquié , 2017) . Different differentiation efficacy among protocols may be attributable to endogenous signaling and Tbx6 transgene expression in our ESCs.
Collectively, we demonstrate that Tbx6 has dramatic effects on nascent mesoderm induction and subsequent lineage specification in PSCs. Our results provide the basis for understanding mesoderm development as well as for the generation of desired cell types for regenerative medicine in the future.
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